Sriwastava, Shitiz http://orcid.org/0000-0001-6844-3287
Tandon, Medha
Podury, Sanjiti
Prasad, Apoorv
Wen, Sijin
Guthrie, Garret
Kakara, Mihir
Jaiswal, Shruti
Subedi, Roshan
Elkhooly, Mahmoud
Lisak, Robert P.
Article History
Received: 3 April 2021
Accepted: 10 May 2021
First Online: 19 May 2021
Declarations
:
: In the last 2 years Dr. Lisak has participated as a speaker in meetings sponsored by and received consulting fees and/or grant support from: Alexion, Argenx, UCB/Ra Pharmaceuticals, Novartis, Mallinckrodt, Genentech/Roche, Chugai, Janssen, GLG Consulting, Alpha Sites Consulting, Schlesinger Group Consulting, Slingshot Consulting, Health Sources, Adivo Associates, Smart Analyst, Clairview, Clarion and Decision Resources. He served as Chair of the Adjudication Committee for a MS clinical trial for MedDay (Biotin study). He is funded by a R21 grant by NINDS “Molecular Characterization of B Cell Exosomes in Multiple Sclerosis” and as site PI for NINDS funded study “LP4/Agrin Antibodies in Double Seronegative Myasthenia Gravis”. He has received publication royalties from Oxford University Press (Neuroimmunology, 2019) and Blackwell Wiley (International Neurology, 2nd Edition, 2016). The rest of the authors have no disclosures.
Free to read: This content has been made available to all.